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Abstract-- We have developed a system to hunt 
and reuse special gene integration sites that allow 
for high and stable gene expression. A vector, 
named pRGFP8, was constructed. The plasmid 
pRGFP8 contains a reporter gene, gfp2 and two 
extraneous DNA fragments. The gene gfp2 makes it 
possible to screen the high expression regions on 
the chromosome. The extraneous DNA fragments 
can help to create the unique loci on the 
chromosome and increase the gene targeting 
frequency by increasing the homology. After 
transfection into Chinese hamster ovary cells 
(CHO) cells, the linearized pRGFP8 can integrate 
into the chromosome of the host cells and form the 
unique sites. With FACS, 90 millions transfected 
cells were sorted and the cells with strongest GFP 
expression were isolated, and then 8 stable high 
expression GFP CHO cell lines were selected as 
candidates for the new host cell.  Taking the unique 
site created by pRGFP8 on the chromosome in the 
new host cells as a targeting locus, the gfp2 gene 
was replaced with the gene of interest, human ifn-
gamma, by transfecting the targeting plasmid 
pRIH-IFN. Then using FACS, the cells with the 
dimmest GFP fluorescence were selected. These 
cells showed they had strong abilities to produce 
the protein of interest, IFN-gamma. During the 
gene targeting experiment, we found there is 
positive correlation between the fluorescence 
density of the GFP CHO host cells and the specific 
production rate of IFN-gamma. This result shows 
that the strategy in our expression system is 
correct: the production of the interesting protein 
increases with the increase fluorescence of the GFP 
host cells. This system, the new host cell lines and 
the targeting vector, can be utilized for highly 
expressing the gene of interest. More importantly, 
by using FACS, we can fully screen all the 
transfected cells, which can reduce the chances of 
losing the best cells. 
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I. INTRODUCTION 
 
Genetically engineered mammalian cells play 
an essential role in pharmaceutical protein 
production because the mammalian cells are 
close to cells found in the human body and their 
products are similar to human’s(1). Multiple 
factors affect recombinant protein production in 
mammalian cells. Factors, such as the specific 
cell line used, the expression vector, 
chromosomal integration site, copy number of 
the integrated recombinant gene, selection 
procedures, cell-culture conditions and medium 
employed can all have a large impact on overall 
production(2).  
Transcription is the first and most important 
step of recombinant gene expression. Two basic 
strategies are used to maximize gene expression 
at the transcriptional level: multiple interesting 
gene copy number and finding a special gene 
integration site that allows for high and stable 
gene expression. 
The copy number of the interesting gene can 
have a significant influence on the expression 
characteristics. On average, higher gene copy 
number correlate with higher expression levels. 
The overexpression of recombinant protein in 
Chinese Hamster Ovary (CHO) cells has been 
achieved by gene amplification. In this method, 
the dihydrofolate reductase (dhfr) gene is 
cotransfected with the gene of interest, then 
selected with the amplification drug 
methotrexate. (3,4). The final selected cell may 
contain hundreds or even thousands transgene 
copy numbers. However, the procedure to isolate 
high copy number clones is extremely time-
consuming. The initial expression level is not 
meaningful, and amplifiable clones cannot be 
identified in any other way. Therefore, a large 
number of clones must be handled initially. 
Additionally, the cells with multiple copies of 
the transgene suffer another critical defect: 
genetic instability. To prevent the loss of 
productivity, the cells must be grown 
continuously in the presence of the respective 
selection drug. 
Based on these considerations, in recent years, 
efforts have been made to use cell clones with 
single or low transgene copy numbers to 
overcome instability without a loss in 
 productivity. Many reports show that single-copy 
integration of a transgene can produce a high and 
stable expression. (5, 6, 7) 
Here we report a strategy to hunt and create 
the region(s) on the chromosome that allows 
high and stable gene expression. The specific 
region(s) are modified to create a unique locus 
for gene retargeting in order to introduce the 
gene of interest. 
 
II.  MATERIALS AND METHODS 
 
Genes:  
gfp and gfp2 genes: gfp gene was generously 
donated from Hastings’ Lab, Department of 
Biology, Harvard University. The gene gfp2 has 
been modified by removing the SpeI site from 
gfp by changing ACTAGT to ACTTGT through 
site-mutagenesis. The expressing product of gfp2 
still had strong fluorescence intensity. 
 
Plasmids: 
Original plasmid: pIND is a high expression 
vector with a CMV promoter and enhancer but 
without a selective marker. Hence, a 1.1 kb 
fragment, which includes the 794 bp neor gene as 
well as the SV40 ploy(A) sequence, was inserted 
into the mammalian expression plasmid pIND. 
The novel recombinant plasmid is named pRN.  
The primary hunting plasmid, pRGFP8, was 
constructed by inserting gfp2 gene and two other 
DNA fragments, termed F1(927bp) and F2 
(1344bp) into pRN. The plasmid pRGFP8, 
8.8kb, contains one recognition site for the 
restriction endonuclease Spe I for linearization 
(Fig1.). 
The second targeting plasmid, pRIH-INF. 
Using the pRGFP8 as a backbone, pRIH-INF 
contains the gene of interest, human interferon-
gamma (ifn-γ) gene (Gene bank accession 
number GI: 184638). A new selective gene, hygr, 
is linked behind the ifn-gamma through an 
internal ribosomal entry site (IRES) for reducing 
the background of the selection. The plasmid 
pRIH-IFN, size 10.56kb, contains only one 
recognition site of Spe I for linearization. 
 
Cell lines: 
The non-recombinant CHO K1 cell line, 
obtained from the American Type Culture 
Collection (ATCC number CCL-61), was 
derived as a subclone from the parental CHO cell 
line initiated from a biopsy of an ovary of an 
adult Chinese hamster. (8) 
γ-CHO cell line was obtained from Dr. Walter 
Fiers. (9) This cell line was created from a 
dihydrofolate reductase deficient CHO cell line 
by cotransfecting the cells with dhfr gene and 
human ifn-γ gene.  
 
Cell culture and transfection: 
The γ-CHO cells were cultured in DMEM 
medium supplemented with 0.25µM 
methotrexate and 5% or 10% fetal bovine serum 
(FBS). (10) 
The CHO K1 cells were cultured in DMEM 
medium containing 10%FBS in 6-well plates at 
the cell density of 0.3 million/well. After an 
overnight culture, the cell confluence reached 
about 60%. The transfection reagent was FuGene 
6. By using 2µg Spe I linearized plasmids mixed 
with 6µl FuGene 6 in 100µl serum-free DMEM 
medium per well, the cells were incubated for 12 
hours. Then the relative antibiotic, such as G418 
or Hygromycin, was added for the selection of 
stable cell lines. Media changes performed every 
24 hr. After the obvious cell death and 3 or 4 
more days of growth, small colonies containing 
about 10 cells were apparent.  
 
FACS sorting for GFP expressing cells: 
The cells from the 6-well plates were washed 
with PBS, trypsinized and resuspended in serum-
free DMEM medium. After centrifugation 
(10min, 200g), cells were dispersed in DMEM at 
the density of 10 millions cells/mL. The 
suspensions were transferred to FACS tubes and 
kept on ice until the test.  After FACS sorting, 
the selected cells were collected in 
DMEM/10%FBS, and then transferred into 6-
well plates with DMEM medium supplemented 
with 10%FBS and relative antibiotics: G418 or 
Hygromycin or both. The GFP fluorescence tests 
were also processed with a fluorescence 
microscope. 
 
Human IFN test:  
The concentrations of IFN-γ were determined 
using an ELISA kit (HyCult Biotechnology b.v., 
Uden, the Netherlands). (11) 
 
Specific production rate, q 
 The specific production rate (q) was 
calculated using the following equation: 
 q=[∆C/t]×[(lnNf-lnNi)/(Nf-Ni)]  
Where ∆C is the change in component 
concentration over the time period t. Nf and Ni 
are the final and initial viable cell densities, 
respectively. 
 
 
III. RESULTS AND DISCUSSION 
 
A.  Hunting for the high expression regions on 
the chromosome and setting a targeting locus 
The transcriptional activity of transgenes in 
mammalian cells critically depends on the sites 
of their integration which is modulated by 
interactions between the promoter and 
surrounding chromatin structures. (7) To exploit 
the high expression regions on the chromosome, 
a designed linearizing vector (hunting plasimd, 
pRGFP8) with gfp2 gene and several extraneous 
DNA fragments is transfected into CHO cells. 
Theoretically, the transfected DNA can integrate 
in the chromosome randomly, and the integration 
site decides the gfp2 expression abilities. 
Therefore, the gfp2-transfected cells have 
different gene expression abilities due to the 
different integrating locations on the 
chromosome. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
After exposure to G418, the transfected cells 
are selected with FACS. The cells with the 
strongest GFP expression are selected as the new 
host cells, which should indicate the gfp gene has 
inserted into the high expression regions on the 
chromosome. At the same time, these extraneous 
DNA fragments, F1 and F2 (nonendogeneous 
with host cell’s) may integrate into the host cell’s 
chromosome as well. These DNA fragments will 
help create a unique locus on the chromosome. 
During the retargeting process, the retargeting 
plasmid, pRIH-INF will easily locate to target 
these loci and this will increase the gene 
targeting frequencies. 
Taking the gfp gene in the new host cells as a 
target locus, after transfecting pRIH-INF into the 
new host cells, the cells whose gfp2 gene is 
knocked out by the interesting gene based on the 
homologous recombination can be easily 
selected with FACS. Therefore, the selected 
stable cells should have strong abilities to 
express the protein of interest. On the whole, by 
using gfp2, the high expression sites on the 
chromosome of cells are marked, and the 
nonendogeneous DNA fragments are introduced 
to create the specific locus in order to increase 
the frequency of homologous recombination. 
 
B.  Strategy for the plasmids constructs 
Homologous recombination in animal cells is 
now a routine technique that is used to modify 
the cells’ genome at any chosen locus. (12, 13) 
Two basic types of targeting vectors, insertion 
and replacement, remain in current use.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
With both types of vectors, increasing the 
length of homology improves the targeting 
frequency (14,15). Successful targeting is 
difficult to achieve with a replacement vector 
when the total length of homology drops below 2 
Kb, although 500 bp of homology on the short 
Fig.1. the linearlized plasmid pRGFP8. Gene-targeting vectors are routinely introduced in cells in a linearized form.  Thus a 
unique restriction enzyme site must be present as a site for linearization. For a replacement gene-targeting vector, the linearization 
site must be outside of the regions of homology. To ensure the recombination vector has only one restriction enzyme site, we 
removed the spe I site of gfp, the new gfp gene is termed gfp2. 
 arm has proved sufficient. An insertion vector is 
linearized within the region of homology and 
homologous recombination will lead to a 
duplication of genomic sequences. Thus, the 
replacement vector is more commonly used.  
 
 
 
 
 
 
 
 
 
 
(A) 
 
 
(B) 
 
 
 
 
 
 
 
 
 
 
 
 
The strategy for designing the hunting plasmid 
is to use special extraneous DNA to modify the 
host cell: not only to mark the high expression 
sites on the chromosome of the host cell, but also 
to set a unique locus for gene targeting and 
replacement. A replacement vector typically 
contains two separate arms of homology to the 
target locus (gfp gene), separated by a region of 
nonhomologous DNA. A nonreciprocal 
homologous recombination event between each 
arm of the vector and the target locus results in 
the replacement of part of the target locus with 
vector sequences. Thus, we introduced two 
extraneous DNA fragments in the short arm in 
order to increase the homology. These 
extraneous DNA fragments should have unique 
sequences that are different with the 
endogeneous DNA of host cell. In our study, we 
chose CHO as the host cell. Since there is not 
information about the entire CHO genomic 
sequence in the gene bank, we used mouse EST 
for the blast tests to select the suitable DNA 
fragments. Two extraneous fragments, termed F1 
(927bp) and F2 (1344bp), were selected, and 
BLAST tests showed both of these fragments 
have low similarity after comparing them with 
the sequence of the entire GenBank Mouse EST 
(2,793,398 sequences; 1,254,021,342 total 
letters). (Fig.2) 
 
C.  gfp2 high expression CHO cell lines 
After being transfected with pRGFP8, the cell 
population has become a cell library, which 
contains thousands, or even millions of cells with 
different gfp2 locations. To get a high-expression 
stable cell line, a two-round expression selection 
was performed. After G418 stable selection, a 
total of about 90 millions transfected cells were 
sorted in the first round on a Becton Dickinson 
FACScan flow cytometer and the top 1% of 
fluorescence cells were collected and 
continuously cultured in DMEM 
mediun/10%FBS containing G418 for two 
weeks. The same FACS sorting was carried out 
again and the top 1% high-fluorescent population 
was collected. The average fluorescence 
intensity of this population was 207.21, and 
comparied to the original gfp-transfected cell 
population, the fluorescence had increased about 
38 times.  
After being sorted with FACS, the selected 
cells were then picked up for single colony 
selection: each cell line was culture about 30-50 
generations, and their offspring were tested on 
the fluorescence performance. Those cells that 
were able to express the inserted gene stably 
were eligible to be used as potential new host 
cells.  
 
D.  Targeting the pre-setting loci 
All of the gfp2 stable high-expression CHO 
cells selected are potential new host cells and 
gene targeting should be performed in order to 
find the cell whose gfp2 gene can be replaced 
easily. We chose the 8 stable GFP CHO cell 
lines as the targeting cells. After 50 generations’ 
culture, all of these cell lines show at least 90% 
positive fluorescence cells (from 90.87% to 
95.91%) in a 10,000-events FACS sorting test.   
Fig. 2.  BLAST tests for F1 (extraneous fragment 1) and F2 
(extraneous fragment 2). (A), Extraneous fragment 1, 
Distribution of 9 Blast hits on the fragment 1, the largest 
fragment is 182bp, with 81% identities. (B), Extraneous 
fragment 2, Distribution of 8 Blast hits on the fragment 2, the 
largest fragment is 160bp, with 98% identities. Because the 
homologous recombination happens when the homologous 
sequence is at least 500bp, the F1 and F2 cannot influence the 
endogeneous chromosome of CHO cell.  
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We chose the human IFN-gamma gene as a 
model gene to replace the gfp in the GFP CHO 
cells. Upon the DNA transfected into GFP CHO 
cells, random integration of the plasmid can lead 
to hygromycin resistance, while homologous 
recombination with the endogenous gfp gene 
causes both hygromycin resistance and GFP 
negative. After transfection with linearized 
pRIH-INF and sorted with FACS, the dimmest 
10% cells were collected and then cultured in 
DMEM medium supplemented with 10% FBS 
and G418 and hygromycin. In the second round 
of FACS sorting, the dimmest 1% of cells were 
collected and cultured in the same conditions and 
then single cell colonies were picked up to test 
their GFP and IFN-gamma productions.  
After gene targeting, five of the eight cell lines 
were found to not be GFP--hygromycinr-IFN+. 
One of reasons for this is that they may contain a 
few gfp gene copies in different positions and 
these gfp2 cannot be all knocked-out at the same 
time. The cells found that meet the above 
condition were A12, A16 and B4.  
Compared to most of the other usages of gene 
targeting, nonhomologous recombination does 
not have significant negative influence on our 
expression system. In fact, the interesting gene 
inserting randomly into chromosome may be 
good for increasing the production of protein of 
interest in most of cases.  
When we isolated the gfp2 knock-out cells, 
these cells were cultured in DMEM medium and 
their specific IFN-gamma productivities were 
determined.  The results show most of the cell 
lines have a high expression level of IFN-gamma 
compared to the control γ-CHO cells. 
Interestingly, there is a positive correlation 
between the fluorescence densities of GFP CHO 
cells and the expression levels of IFN-gamma. 
(Fig.3.) 
On average, the productivity of newly targeted 
cells is predictable based on the fluorescence 
density of the original GFP cell lines. However, 
when individual clones are compared, this 
correlation does not work well because of the 
drastic differences in the expression level of 
individual clones. Nonhomologous 
recombination may be one of important reasons 
for the variance of the productivities among the 
individual clones. If we neglect the possibility 
that the nonhomologous recombination may 
cause fatal mutants, nonhomologous 
recombination is good for increasing gene 
expression.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
E.  Influence of two extrous DNA fragments on 
the gene targeting frequency 
For increasing the gene targeting frequency, 
we introduced two extraneous DNA fragments, 
F1 and F2 in the vectors, which would have 
integrated into chromosome to create the unique 
locus. For the cell lines A16 and B4, the gene 
targeting frequency was 1.2 ×10-5 and 2.0×10-5 
respectively. Systematic studies of the targeting 
ratio at the APRT locus in CHO cells as a 
function of transfection method have shown that 
the targeting ratio varies from 1:15 for 
microinjection to 1:370,000 for Fugene-6. (16-
18). The transfection method can influence the 
targeting frequency dramatically. As we used 
FuGene-6 as the transfection reagent, the gene 
targeting frequency reached to the similar level 
shown above, this means the extraneous DNA 
fragments were helpful. Moreover, the same 
targeting tests for A16 cells were performed with 
the plasmid without F1 and F2 fragments (data 
not shown). Without F1 and F2 fragments, the 
homology of the short arm of the vector 
decreases from 3.2 Kb to 0.9Kb, and this caused 
at least a 100-fold decrease in the targeting 
frequency. 
Fig. 3. The correlation between the fluorescence densities 
of the origianal GFP-CHO cell lines and the interferon-gamma 
production abilities of the gfp2 knock-out cell lines. The qIFN 
data were determinate at the day 3’s culture in the 
DMEM/5%FBS medium. The fluorescence density of the 
GFP-CHO cell lines were determined before they were 
transfected with pRIH-INF. The qIFN of γCHO was 
1.12pg/cell/d.
 This result supports that there is just one gfp2 
gene copy in both the A16 and B4 cell lines. 
However, for the transfected vector, whether it is 
initially circular or linear, the ends may become 
truncated during the integration process.(14,15) 
Thus, the pre-set locus in these two different 
cells may not be same , neither are the total 
homology between the targeting locus and the 
linearized pRIH-INF. This makes the targeting 
frequency for these cell lines, A16 and B4, 
different. 
The targeting frequency for A12 was lower, 
about 1×10-7. We consider that there may be at 
least two gfp2 gene copies in A12. As for the 
other 5 cell lines that were not found the purpose 
cells after gene targeting, they may contain even 
more than two gfp2 gene copies. Based on 
statistical estimation, we may obtain only one 
cell where all the copies of the gfp2 gene are 
knocked-out for every 2 billion transfected cells 
which contain 3 copies of expressed-gfp2 gene.  
The system described here is a good method 
for high expression of the interesting gene. As 
opposed to the common targeting method, 
nonhomology recombination is not a issue 
anymore. With the extraneous DNA fragments 
F1 and F2, the pre-set loci are easily targeted. 
The positive correlation between fluorescence 
density of the GFP-CHO cells and protein 
productivity of the purpose cells makes the 
targeting results predicated. However, 
considering that the genomic DNA of CHO cells 
may be more than 1 billion base pairs and any 
base pair difference in integration may cause the 
difference of gene expression level, more work 
should be done in hunting for the high 
expression regions. A much larger transfected 
cell number for sorting may be a good solution 
in obtaining the cell line which contains just one 
transgene copy and has a stable and high gene 
expression level.  
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